Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by capebretongirlon Apr 06, 2021 1:27pm
99 Views
Post# 32942426

RE:RE:RE:Seriously

RE:RE:RE:Seriously
gojotv! wrote: You're right, guys... This is complete madness.
There was clearly a concerted effort to bash the CEO, (even accounts created for just that purpose) and to create a false panic when fundamentals are really so good.
They failed to bring the price down and buy back in before the rebound on Thursday, so they've been working everyone's nerves since.
Pages and pages of bashing so they can get back into this game. Meanwhile, profits are still pouring in, Covid testing isn't going away - in fact, it's going over-the-counter!
Aristotle has been launched to an eagerly awaiting market here and overseas,
Telehealth systems are being put into place. The whole approach to cancer testing and treatment is being re-worked, and SZLS is at the forefront!
This is what Warren Buffet was always on about... "Be greedy when others are fearful."
Words to live by.
GLTA except the fraud-spreading bashers.


molotov420 wrote: This company is not in any kind of trouble. In fact its the exact opposite. Although the timing of the NRs was messed up they actually announced what they promissed, albeit not in the way we expected. 

Selling at this level will bite you in the butt. Seen it a million times before. This is not going any lower and will likely rebound quickly. 

-Millions in the bank; 
-Covid revenue coming in and cancer revenue growing; 
-Aristotle launched and gauranteed revenue coming from that soon. 

The next few months should be fun. GLTA. This company is growing quickly now!


Your post and Molotov's bring a voice of reason and sensibility to this situation.  There is a lot of panic selling going on today - there is nothing wrong with voicing disapproval of Tripp's handling of this situation, however the bashers have an entirely different agenda. 

<< Previous
Bullboard Posts
Next >>